Nasus Pharma Ltd cotiza a 3.32 USD y tiene una capitalización bursátil de $39M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epin…
| Métrica | NSRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -0.4% | -38.6% | +38.2% |
| Net Margin | -0.5% | -33.6% | +33.1% |
| FCF Margin | -0.4% | -13.9% | +13.5% |
| ROE | -211.6% | -40.4% | -171.2% |
| ROA | -117.0% | -32.0% | -85.0% |
| Current Ratio | 2.24 | 2.84 | -0.60 |
| Debt / Equity | — | 0.28 | — |